GHSI (guardionhealth.com) Bozor qiymatining balans qiymatiga nisbati

Guardion Health Sciences, Inc. (GHSI) kompaniyasining rasmiy ramzlari

Guardion Health Science o'zining dalillarga asoslangan ko'rish qobiliyati uchun nutratsevtikalariga nisbatan bemorlarning ishonchiga tayanadi. Brend distributsiyasi sinergiyasi Lumega-Z ni targ'ib qilish uchun klinikalarga bo'lgan sherikliklar orqali amalga oshiriladi, ishlab chiqarishni autsorsing qilish orqali esa ekologik ta'sir minimallashtirilgan. Kompaniyaning nisbiy kapitalizatsiya ko'rsatkichi bozor konsensusini tasdiqlaydi va eng so'nggi qiymat 0.30 deb qayd etilgan.

GHSI Guardion Health: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 19.10.2024 oraligʻida
Guardion Health Sciences Inc. original mahsuloti

Guardion Health Science (GHSI) uchun risklarni filtrlash maqsadida aktivlarning haddan tashqari qimmat baholanganlik darajasini baholash zarur. Ushbu ko'rsatkich bozor qiymatining sof aktivlarga nisbati sifatida hisoblanadi va birja kotirovkalari bilan balans qiymati o'rtasidagi farqni o'lchaydi. Bozor qiymatining balans qiymatiga nisbati o'zgarishini tahlil qilish fundamental bazadan spekulyativ chekinishlarni ochib beradi. Guardion Health Science uchun bunday premium bozorning oftalmolog-olimlar kapitaliga va ularning dalillarga asoslangan tadqiqotlari qiymatiga bo'lgan ishonchini aks ettiradi.

Asosiy raqobatchilar

Alcon Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|BLCO (bausch.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Glaukos GKOS|Sof aktivlarga nisbatan bozor kapitallashuvi Apellis Pharmaceuticals, Inc.|Belite Bio, Inc. (BLTE) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Ocular Pharma (OCUL)|Bozor kapitallashuvining balans qiymatiga nisbati HROW (Harrow, Inc.)|viridiantherapeutics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati LENZ Therapeutics (LENZ)|OCS: Balans qiymatiga nisbatan bozor qiymati|EYPT (EyePoint Pharma) - Bozor qiymatining balans qiymatiga nisbati|Kodiak Corp (KOD) - Kapitallashuvning sof aktivlarga nisbati|ALDX (Aldeyra Therapeutics Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Kala Pharmaceuticals (KALA)|Opus Genetics Inc (IRD) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati okyopharma.com (OKYO)|ADVM: Bozor kapitallashuvining balans qiymatiga nisbati|OTLK - Bozor qiymatining balans qiymatiga koeffitsiyenti|CLSD (Clearside Biomedical) - Kapitallashuvning sof aktivlarga nisbati|NBY - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati KPRX|ALIM (Alimera Sciences, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|EYEN: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Ocuphire Corporation|OPT: Bozor kapitallashuvining balans qiymatiga nisbati